Changyou Zhou Selected Research

Changyou Zhou Research Topics

7	Neoplasms (Cancer) 05/2024 - 10/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 12/2019
2	Brain Neoplasms (Brain Tumor) 10/2020 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2015
2	Ischemia 01/2017 - 09/2014
2	Obesity 10/2010 - 08/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Stomach Neoplasms (Stomach Cancer) 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Glioma (Gliomas) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Inflammation (Inflammations) 01/2017
1	Suppuration 01/2017
1	Vascular Remodeling 01/2017
1	Osteoporosis 01/2016
1	Melanoma (Melanoma, Malignant) 10/2015
1	Type 2 Diabetes Mellitus (MODY) 08/2008

2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2017
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 12/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2020 - 01/2020
2	HMGB1 Protein (HMG1)IBA 01/2017 - 09/2014
1	venetoclaxIBA 05/2024
1	Phosphotransferases (Kinase)IBA 01/2023
1	PlatinumIBA 12/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020
1	EnzymesIBA 12/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	pamiparibIBA 01/2020
1	olaparibIBA 01/2020
1	AZD 6244IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	mirdametinibIBA 01/2020
1	Alkylating AgentsIBA 01/2020
1	Calcium-Sensing ReceptorsIBA 01/2016
1	cyclopropanecarboxylic acidIBA 01/2016
1	dabrafenibIBA 10/2015
1	BGB-283IBA 10/2015
1	VemurafenibIBA 10/2015
1	Antineoplastic Agents (Antineoplastics)IBA 10/2015
1	raf KinasesIBA 10/2015
1	Heparin (Liquaemin)FDA LinkGeneric 09/2014
1	lysosomal Pro-X carboxypeptidaseIBA 10/2010
1	Streptozocin (Streptozotocin)FDA Link 08/2008
1	Glucose (Dextrose)FDA LinkGeneric 08/2008
1	Guanine Nucleotide Dissociation Inhibitors (GDIs)IBA 08/2008

4	Therapeutics 01/2023 - 01/2020
1	Oral Administration 01/2020